Hemodiafiltration: clinical evidence and remaining questions (Q37687067)

22 August 2017

1 reference

title

Hemodiafiltration: clinical evidence and remaining questions (English)

1 reference

22 August 2017

1 reference

3

Bernard Canaud

1 reference

22 August 2017

Peter J Blankestijn

1

1 reference

22 August 2017

Ingrid Ledebo

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

3 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

77

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

581-587

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.541

22 August 2017

exact match

0 references

cites work

Effect of dialysis dose and membrane flux in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Effect of membrane permeability on survival of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

On-line hemodiafiltration: technique and therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Changing paradigms of renal replacement therapy in chronic kidney disease patients: ultrapure dialysis fluid and high-efficiency hemodiafiltration for all?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Optimization of mid-dilution haemodiafiltration: technique and performance.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Haemodiafiltration: promise for the future?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Results from the RISCAVID study: is haemodiafiltration associated with improved survival?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

On-line hemodiafiltration in Southeast Asia: a three-year prospective study of a single center

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

On-line haemodiafiltration decreases serum TNFalpha levels in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Inflammation and oxidative stress in patients on hemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

On-Line Haemodiafiltration versus Haemodialysis: Stable Haematocrit with Less Erythropoietin and Improvement of Other Relevant Blood Parameters

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Clinical improvement by increased frequency of on-line hemodialfiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Predilution haemofiltration--the Second Sardinian Multicentre Study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Change from conventional haemodiafiltration to on-line haemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Nutritional status in hemodialysis patients: options for on-line convective treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2009.541

1 reference

7 January 2021

Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Dialyzer membrane permeability and survival in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Mortality risk for patients receiving hemodiafiltration versus hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Clinical use of high-efficiency hemodialysis treatments: long-term assessment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Patient- and treatment-related determinants of convective volume in post-dilution haemodiafiltration in clinical practice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Overview of clinical studies in hemodiafiltration: what do we need now ?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Optimizing haemodiafiltration: tools, strategy and remaining questions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Heparin-free dialysis with an on-line hemodiafiltration system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Heparin free dialysis: comparative data and results in high risk patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

High permeability of dialysis membranes: what is the limit of albumin loss?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Does convective dialysis therapy applied daily approach renal blood purification?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.541

7 January 2021

Identifiers

DOI

10.1038/KI.2009.541

1 reference

22 August 2017

1 reference